|
The effect of deprenyl treatment
on directional and velocity control of arm movement in patients with early
stages of Parkinson's disease.
Giladi N, Honigman S, Hocherman
S
Department of Neurology,
Tel-Aviv Medical Center,
Sackler School of Medicine,
Israel
Clin Neuropharmacol 1999 Jan-Feb;22(1):54-9
ABSTRACT
Visual motor control (VMC) of arm movements is
disturbed in patients with Parkinson's disease. The effect of
antiparkinsonian medications on VMC is unknown. To assess the effect of
deprenyl, a monoamine oxidase type B inhibitor, on VMC in the early stages
of parkinsonism. Fourteen recently diagnosed, unmedicated patients with
primary degenerative parkinsonism, mean age 61.9 +/- 2.8 years, were
assessed by a computerized VMC system for tracking and tracing on a sine
wave, circle, and square. Score was given for total time of test
performance, directional error, arm velocity, and number of interruptions in
tracking. All patients performed the first VMC test at baseline, prior to
any antiparkinsonian treatment. The second test was performed after a month
of treatment with 2.5 mg/d of deprenyl, and the third test was done after an
additional month of treatment with 10 mg/d of deprenyl. Results were
compared with 15 healthy volunteers with a mean age of 63.1 +/- 1.2 years.
Parkinsonian patients performed significantly poorer on the VMC when
compared to controls. Tracing was more affected than tracking. Tracing total
time was almost twice as long as for controls (p < .0005). Treatment with
2.5 mg/d and 10 mg/d of deprenyl improved performance significantly (p <
.05 and p < .005, respectively). Velocity of arm movement was not
affected by deprenyl treatment in either dose. Directional control
(tracing), severely disturbed in the parkinsonian group, improved back to
the performance of healthy controls after 10 mg/d of deprenyl. In recently
diagnosed parkinsonian patients internally guided VMC tasks were disturbed
more than externally guided ones. Deprenyl treatment
selectively improved directional control of arm movement in a dose related
manner.
|